Jiangsu Hengrui Pharmaceuticals Co.,Ltd (HKG:1276)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
66.50
+0.50 (0.76%)
At close: Feb 27, 2026
16.67%
Market Cap 427.80B
Revenue (ttm) 33.86B
Net Income (ttm) 8.16B
Shares Out n/a
EPS (ttm) 1.27
PE Ratio 52.41
Forward PE 37.64
Dividend n/a
Ex-Dividend Date n/a
Volume 2,711,390
Average Volume 2,751,648
Open 66.00
Previous Close 66.00
Day's Range 65.45 - 67.80
52-Week Range 52.50 - 95.20
Beta n/a
RSI 35.79
Earnings Date Mar 26, 2026

About HKG:1276

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. It develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China. [Read more]

Sector Healthcare
Founded 1970
Employees 20,238
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1276
Full Company Profile

Financial Performance

In 2024, HKG:1276's revenue was 27.98 billion, an increase of 22.63% compared to the previous year's 22.82 billion. Earnings were 6.34 billion, an increase of 47.28%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.